Landscape Capital Management, L.L.C. Glaukos Corp Transaction History

Landscape Capital Management, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$54.18 - $65.64 $1.63 Million - $1.98 Million	-30,101 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$58.58 - $83.91 $451,827 - $647,197	-7,713 Reduced 20.4%	30,101 $1.88 Million
Q2 2019 Aug 08, 2019	BUY	$63.59 - $78.71 $2.4 Million - $2.98 Million	37,814 New	37,814 $2.85 Million
Q1 2018 May 11, 2018	SELL	$26.05 - $34.5 $368,138 - $487,554	-14,132 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$24.5 - $36.01 $346,234 - $508,893	14,132	14,132 $362,000

340

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.85B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.